top banner imagetop banner mobile image

Press Releases

Date Title
10/15/21
TherapeuticsMD Announces Appointment of Mark Glickman as Chief Business Officer
09/02/21
Therapeutics MD Is Urging Women to ‘Take Pause’ During Menopause Awareness Month
08/23/21
TherapeuticsMD Announces Issuance of a J-Code for ANNOVERA® to Be Utilized in the Public Health Sector
08/09/21
TherapeuticsMD Announces Appointment of Hugh O’Dowd as President
08/04/21
TherapeuticsMD Announces Second Quarter 2021 Financial Results
07/26/21
TherapeuticsMD to Report Second Quarter 2021 Results on August 4, 2021
05/25/21
TherapeuticsMD Announces Submission of Low Dose BIJUVA® 0.5 mg/100 mg Supplemental New Drug Application to FDA
05/24/21
The Sun Sentinel Names TherapeuticsMD, Inc. a Winner of the South Florida Top Workplaces 2021 Award
05/06/21
TherapeuticsMD Announces First Quarter 2021 Financial Results
05/03/21
TherapeuticsMD Announces Poster Presentation of ANNOVERA® Data at the American College of Obstetricians and Gynecologists 2021 Annual Meeting
04/29/21
TherapeuticsMD to Report First Quarter 2021 Results on May 6, 2021
04/08/21
TherapeuticsMD and Theramex Announce the Approval of BIJUVE® Capsules Indicated for Hormone Replacement Therapy in the United Kingdom and Under the Trade Name BIJUVA® in Belgium
03/02/21
TherapeuticsMD Announces Fourth Quarter and Full-Year 2020 Financial Results
03/01/21
TherapeuticsMD Announces Participation in Upcoming Investor Conferences
02/23/21
TherapeuticsMD to Report Fourth Quarter 2020 Results on March 2, 2021
02/16/21
TherapeuticsMD Announces Closing of its Underwritten Public Offering of Common Stock
02/11/21
TherapeuticsMD Announces Pricing of $110 Million Public Offering of Common Stock
02/10/21
TherapeuticsMD Announces Underwritten Public Offering of its Common Stock